{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:26:23Z","timestamp":1787243183251,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Neurosurgical Society of Virginias"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05324-2","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:24:00Z","timestamp":1763540640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of temozolomide dosing on outcome in glioblastoma"],"prefix":"10.1007","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8572-8889","authenticated-orcid":false,"given":"Anuradha","family":"Raghu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Killar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"5","key":"5324_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1188\/16.cjon.s1.2-8","volume":"20","author":"M Davis","year":"2016","unstructured":"Davis M (2016) Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs 20(5):S2\u2013S8. https:\/\/doi.org\/10.1188\/16.cjon.s1.2-8","journal-title":"Clin J Oncol Nurs"},{"issue":"10","key":"5324_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/nejmoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/nejmoa043330","journal-title":"N Engl J Med"},{"issue":"3","key":"5324_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ijrobp.2010.06.012","volume":"81","author":"J Li","year":"2011","unstructured":"Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ Jr, Mehta MP (2011) Validation and simplification of the radiation therapy oncology group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys 81(3):623\u2013630. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5324_CR4","doi-asserted-by":"publisher","unstructured":"Bell, E. H., Pugh, S. L., McElroy, J. P., Gilbert, M. R., Mehta, M. P., Klimowicz, A. C., Magliocco, A. M., Bredel, M., Robe, P. A., Grosu, A. L., Stupp, R., Curran, W. J., Becker, A. P., Salavaggione, A. L., Barnholtz-Sloan, J. S., Aldape, K., Blumenthal, D. T., Brown, P. D., Glass, J., & Souhami, L. (2017) Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era. JAMA Oncology 3(6):784. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6020","DOI":"10.1001\/jamaoncol.2016.6020"},{"issue":"11","key":"5324_CR5","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s00066-017-1110-4","volume":"193","author":"SB Nachbichler","year":"2017","unstructured":"Nachbichler SB, Schupp G, Ballhausen H, Niyazi M, Belka C (2017) Temozolomide during radiotherapy of glioblastoma multiforme. Strahlenther Onkol 193(11):890\u2013896. https:\/\/doi.org\/10.1007\/s00066-017-1110-4","journal-title":"Strahlenther Onkol"},{"key":"5324_CR6","unstructured":"Temozolomide: Drug Information. UpToDate. (n.d.). https:\/\/www.uptodate.com\/contents\/temozolomide-drug-information?search=temozolomide%26usage_type=panel%26kp_tab=drug_general%26source=panel_search_result%26selectedTitle=1~79%26display_rank=1"},{"issue":"12","key":"5324_CR7","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s10552-010-9639-x","volume":"21","author":"LW Jones","year":"2010","unstructured":"Jones LW, Ali-Osman F, Lipp ES, Marcello J, McCarthy BJ, McCoy L, Rice T, Wrensch M, Il\u2019yasova D (2010) Association between body mass index and mortality in patients with glioblastoma mutliforme. Cancer Causes Control 21(12):2195\u20132201. https:\/\/doi.org\/10.1007\/s10552-010-9639-x","journal-title":"Cancer Causes Control"},{"issue":"4","key":"5324_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ijrobp.2007.11.064","volume":"71","author":"SE Combs","year":"2008","unstructured":"Combs SE, Wagner J, Bischof M, Welzel T, Edler L, Rausch R, Wagner F, Zabel-du Bois A, Debus J, Schulz-Ertner D (2008) Radiochemotherapy in patients with primary glioblastoma comparing two Temozolomide dose regimens. Int J Radiation Oncology*Biology*Physics 71(4):999\u20131005. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.11.064","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"1","key":"5324_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/030089160709300107","volume":"93","author":"JK Antonella Scheda","year":"2007","unstructured":"Antonella Scheda JK, Finjap J, Tuettenberg, Brockmann MA, Hochhaus A, Hofheinz R, Lohr F, Wenz F (2007) Efficacy of different regimens of adjuvant radiochemotherapy for treatment of glioblastoma. Tumori J 93(1):31\u201336. https:\/\/doi.org\/10.1177\/030089160709300107","journal-title":"Tumori J"},{"issue":"9","key":"5324_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","volume":"4","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS (2018) Adult glioma incidence and survival by race or ethnicity in the united States from 2000 to 2014. JAMA Oncol 4(9):1254\u20131262. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1789","journal-title":"JAMA Oncol"},{"issue":"1","key":"5324_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000170088","volume":"32","author":"I Zawlik","year":"2009","unstructured":"Zawlik I, Vaccarella S, Kita D, Mittelbronn M, Franceschi S, Ohgaki H (2009) Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study. Neuroepidemiology 32(1):21\u201329. https:\/\/doi.org\/10.1159\/000170088","journal-title":"Neuroepidemiology"},{"issue":"4","key":"5324_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ijrobp.2007.11.064","volume":"71","author":"SE Combs","year":"2008","unstructured":"Combs SE, Wagner J, Bischof M et al (2008) Radiochemotherapy in patients with primary glioblastoma comparing two Temozolomide dose regimens. Int J Radiat Oncol Biol Phys 71(4):999\u20131005. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.11.064","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5324_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/030089160709300107","volume":"93","author":"A Scheda","year":"2007","unstructured":"Scheda A, Finjap JK, Tuettenberg J et al (2007) Efficacy of different regimens of adjuvant radiochemotherapy for treatment of glioblastoma. Tumori 93(1):31\u201336. https:\/\/doi.org\/10.1177\/030089160709300107","journal-title":"Tumori"},{"issue":"6","key":"5324_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/nop\/npz006","volume":"6","author":"HI Robins","year":"2019","unstructured":"Robins HI, Eickhoff J, Gilbert MR et al (2019) The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525. Neurooncol Pract 6(6):473\u2013478. https:\/\/doi.org\/10.1093\/nop\/npz006","journal-title":"Neurooncol Pract"},{"issue":"6","key":"5324_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1215\/15228517-2008-120","volume":"11","author":"TS Armstrong","year":"2009","unstructured":"Armstrong TS, Cao Y, Scheurer ME et al (2009) Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol Dec 11(6):825\u2013832. https:\/\/doi.org\/10.1215\/15228517-2008-120","journal-title":"Neuro Oncol Dec"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05324-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05324-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05324-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:35:05Z","timestamp":1767702905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05324-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5324"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05324-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by INOVA IRB with a waiver of consent and conducted in accordance with teh Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}